- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07646444
OPN Balloon for SAFE Recanalization of Calcified Coronary Lesions (OPEN-SAFE)
June 10, 2026 updated by: Minneapolis Heart Institute Foundation
OPN Balloon for SAFE Recanalization of Calcified Coronary Lesions (OPEN-SAFE Registry)
The goal of the OPEN-SAFE registry is to describe the contemporary use and outcomes of SIS-OPN in North America.
Study Overview
Status
Not yet recruiting
Intervention / Treatment
Study Type
Observational
Enrollment (Estimated)
300
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Bavana V Rangan, BDS, MPH
- Phone Number: 612-863-4768
- Email: Bavana.Rangan@allina.com
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
Individuals over the age of 18 who have undergone clinically indicated PCI with the use of the OPN balloon
Description
Inclusion Criteria:
- Age 18 years or older
- Subjects who underwent a clinically indicated PCI procedure that involved at least one OPN balloon
- Date range for data collection will be from February 1, 2023 to December 31, 2028
Exclusion Criteria:
- Subjects who have opted out of being included in research related data collection
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
In-Hospital Outcomes
Time Frame: periprocedural
|
Descriptive summaries of incidence of in-hospital outcomes and MACE
|
periprocedural
|
|
Treatment Utilization
Time Frame: intra-procedural
|
descriptive summaries of various treatments utilized before and after use of the OPN balloon
|
intra-procedural
|
|
Predictors of Success and Failure for the OPN Balloon
Time Frame: intra-procedural
|
Assess predictors for failure of the OPN balloon
|
intra-procedural
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
June 1, 2026
Primary Completion (Estimated)
January 1, 2027
Study Completion (Estimated)
June 1, 2027
Study Registration Dates
First Submitted
May 28, 2026
First Submitted That Met QC Criteria
June 10, 2026
First Posted (Actual)
June 12, 2026
Study Record Updates
Last Update Posted (Actual)
June 12, 2026
Last Update Submitted That Met QC Criteria
June 10, 2026
Last Verified
June 1, 2026
More Information
Terms related to this study
Other Study ID Numbers
- 2437403-1
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
Yes
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on In Stent Restenosis
-
Boston Scientific CorporationActive, not recruiting
-
Boston Scientific CorporationActive, not recruiting
-
Klinikum CoburgUnknown
-
IRCCS Azienda Ospedaliero-Universitaria di BolognaNot yet recruiting
-
Assiut UniversityNot yet recruiting
-
Luzerner KantonsspitalUnknown
-
Fundación Médica para la Investigación y Desarrollo...Abbott Medical Devices; Hospital San Carlos, Madrid; B.Braun Surgical SAUnknown
-
Cordis CorporationCompletedIn-Stent RestenosisUnited States
-
Second Affiliated Hospital, School of Medicine,...West China Hospital; The Third Xiangya Hospital of Central South University; Shanghai... and other collaboratorsUnknownCoronary In-stent RestenosisChina
-
Abbott Medical DevicesCompletedIn-stent RestenosisSpain, France, Georgia, Lithuania
Clinical Trials on non compliant balloon
-
Odense University HospitalActive, not recruitingMyocardial Infarction | Myocardial Ischemia | Heart Diseases | Cardiovascular Diseases | Coronary Artery Disease | Coronary Disease | Arterial Occlusive Diseases | Stable Angina | Coronary Artery Stenosis | Atherosclerosis of ArteryDenmark
-
Fundación EPICCompletedCardiovascular Diseases | Arterial DiseaseSpain
-
Centre Hospitalier Universitaire de NiceCompleted
-
Cardiology Center AgelUnknownCoronary Artery Stenosis
-
Soonchunhyang University HospitalBoston Scientific Corporation; The Catholic University of Korea; Eulji University and other collaboratorsRecruiting
-
Lin ZhaoChina-Japan Friendship Hospital; Xin Hua Hospital Affiliated to Shanghai Jiao...Not yet recruitingVascular CalcificationChina
-
Shanghai Bluesail Boyuan Medical Technology Co....Not yet recruiting
-
InnoRa GmbHTerminatedLesions in the Superficial Femoral Artery and/or Popliteal Artery Pars I/IIGermany
-
St. Francis Hospital, New YorkAkiko Maehara, MDUnknown
-
SIS Medical AGUnknownCoronary Artery Disease | Stable Angina | Unstable Angina | AnginaSwitzerland